Meet the Leaders Driving EarlySense's Success
Mr. Johnson brings with him over 15 years of experience as a healthcare and healthtech executive and investor. Throughout his career, he has served in multiple senior management positions, including managing director of healthcare private equity investments at Sowell & Co., CEO of CareCycle Solutions and CEO of HealthBridge In-Home Care.
Mr. Johnson joined EarlySense in 2019 to advance the company’s goal to become the standard of care for contact-free, continuous monitoring solutions for the
Mr. Johnson holds a BA in Economics from Southern Methodist University.
President, EarlySense Inc.
Mr. O’Malley has more than 25 years of direct relevant experience in the medical technology industry. Throughout his career, Mr. O’Malley has led teams to commercial success in providing real value to patients and clinicians.
Prior to joining EarlySense Inc., he served as the Vice President of the US Hospital Division at ZOLL Medical, a position he held since 2007. Under Mr. O’Malley’s leadership, this division substantially increased its market share in US hospitals and generated significant sales growth.
Prior to ZOLL, he was President and CEO of Medwave, Inc., a small cap public company that developed, marketed and sold advanced sensor based blood pressure monitoring products. Mr. O’Malley also spent 16 years at Siemens where he reached the position of Vice President and Division Manager for the Electro Medical Division in North America.
Mr. O’Malley holds an AAS Degree in Bio Medical Engineering and completed his undergraduate studies in Business Management and Marketing from DePaul University in Chicago.
VP of International Sales and Marketing
Ms. Scialom has more than 20 years of experience in the medical device industry. Her career includes acting as the CEO of Pollogen Ltd. and turning it into a profitable enterprise by doubling its sales.
Formerly, Ms. Scialom served as the VP of Sales & Marketing at UltraShape Ltd., where she drove sales from $0 to ~$50MM in under 3 years. Prior to UltraShape Ltd., Ms. Scialom acted as the General Manager of Sunlight Medical Europe and established the company as a market leader in Europe. Ms. Scialom has proven success in launching new technologies, creating new markets, leading business development and top line sales growth.
Ms. Scialom holds a B.Sc. in Economics and Management from the Hebrew University of Jerusalem and an MBA from Ben-Gurion University.
Michael A. DeVita MD
Michael A. DeVita, MD, brings with him more than 35 years of medical experience as an intensivist, and is a renowned innovator and promoter of rapid response systems. He is an author of over 100 peer-reviewed articles and dozens of textbook chapters in the fields of rapid response, critical care, simulation education, and ethics. He is also the lead editor of the groundbreaking “Textbook of Rapid Response Systems.” which is in its second edition.
Dr. DeVita joined EarlySense in 2017 to continue his decades-long mission of creating a standard of care for continuous monitoring in all healthcare settings. In addition to his role as EarlySense’s CMO, he also serves as the Medical Director of Critical Care at Harlem Hospital in New York City. Dr. DeVita received his medical degree from Georgetown University and completed his residency at Georgetown University Hospital, specializing in internal medicine
Mr. Gal has more than 25 years of experience in several CFO and executive management positions from startup to public companies in various fields, including Memco Software (NASDAQ: MEMC) Bogen communication (NASDAQ: Bogn) and Aryt (NASDAQ: ARYT and TASE)
Mr. Gal is a Certified Public Accountant (CPA) and holds a B.Sc. in Economics from the Ben-Gurion University.
VP of Operations
Mr. Cohn has held various senior operation and development positions. Prior to joining EarlySense, Mr. Cohn served as the VP of Operations at MainNet Communications.
He also served as the Operations Director at UltraShape Ltd. and as the VP of Operations & Engineering at Sunlight Medical Ltd, where he had earlier served as the Director of Development & Engineering. Mr. Cohn was also a Project Manager at Mashik, an Israeli Industrial Engineering and Management Consultant Company.
Mr. Cohn holds an MBA. in Finance from Bar Ilan University and a B.Sc. in Industrial Engineering and Management from Ben-Gurion University.
CTO, VP Research & Development
Guy has more than 10 years of experience in several positions in the medical industry as well as in the Defense Industry. He has a B.SC degree in Computers engineering from the Technion Israel Institute of Technology and holds an MBA from the Tel Aviv University. Guy led multidisciplinary R&D teams focused on signal processing solutions and sensors on a variety of platforms. Among other positions he served as the leader of large scale integration projects in Rafael, Director of Development in Nexense, and Head of Logic Design Team in Paratec.
Guy is the author of several issued and pending patents.
VP of Clinical, Regulatory Affairs and QA
Ms. Argaman has served in a variety of senior management positions in the medical device field. She also has vital experience in running international clinical trials in US, Europe and Japan and vast experience in submission and obtaining regulatory approvals, including FDA/ PMA and 510k Applications for Class ll and lll devices, CE and JPAL (Shonin) approvals.
Prior to joining EarlySense, Ms. Argaman served as the Director of Clinical and Regulatory Affairs at Glucon Medical, developer of non-invasive glucose monitoring device as well as various other companies developing medical, therapeutic, and diagnostic and/or IVD devices.
She holds a M.Sc. in Physical Chemistry from Tel Aviv University.
VP Human Resources, EarlySense Inc.
Ms. Ritte joined the company close to its inception and took a major part in building the operation and team. Over the years she has been involved in various processes including administration, operations, clinical trials and support, along with building and leading all HR processes in the company. She currently serves as EarlySense’s VP of Human Resources.
Ms. Ritte successfully completed a professional Welfare Officer Course at the Israeli Defense Force and served as a Welfare Officer at the IDF’s Freight Unit.
Ms. Ritte holds a BA in Behavioral Sciences from Ben-Gurion University.
Zvika Shinar Ph.D.
Dr. Shinar brings vast experience in coupling of sensor physics and physiological parameters. Leading teams of developers to harness algorithms power, machine learning & data science to find solutions to challenging problems in physiological monitoring. Author of peer-reviewed publications and patents on Heart Rate Variability, the limits of measurements with the cardio-ballistic effect, and sleep. Special interest in arrhythmia, and breathing patterns.
Dr. Shinar holds a Ph.D. in Medical Physics from Tel-Aviv University, where he also teaches a course on continuous monitoring of vital signs in the department of Biomedical Engineering.
Chairman of the Board
Mr. Harel, General Partner at Pitango Venture Capital is a veteran of the life sciences industry. He has fifteen years of experience, covering a wide range of activities, from basic business and technology development to corporate executive management, in areas such as pharmaceutical development, drug delivery, medical devices and diagnostics.
Before joining Pitango, Mr. Harel was Director of Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) where he was responsible for strategic planning, in-licensing and M&A activities. Prior to his role at Nektar, he held various management positions at leading companies both in Israel and in the U.S. including IDEXX Laboratories (NASDAQ: IDXX) and IDGene Pharmaceuticals.
Mr. Soderberg is the Managing Partner of Worthy Ventures Resources, LLC, a private investment company he founded in February 2010.
Mr. Soderberg is also a Board Member of Greatbatch Inc. (NYSE: GB) and Chairman of the Board of HealthSense . Mr. Soderberg retired in January 2010 as President and Chief Executive Officer of Hill-Rom Holdings, Inc. (NYSE: HRC), a position he held since March 2006. Prior to that , he was President and Chief Executive Officer of Welch Allyn, Inc., and for the seven years prior to that, Chief Operating Officer of Welch Allyn’s medical products business.
Mr. Soderberg also held a number of positions over a twenty-three year career with Johnson & Johnson, where his final position was President of one of its operating subsidiaries. He had also served on the Board of Directors of Hill-Rom (formerly Hillenbrand Industries) and AdvaMed. Mr. Soderberg is a former Director of Constellation Brands, Inc. (NYSE: STZ) and Welch Allyn, Inc.
John R. Barr
Mr. Barr earned his experience serving at some innovative and successful medical device companies. He was most recently Executive Vice President and President of Global Surgical at Bausch & Lomb Holdings Incorporated until the acquisition of Bausch and Lomb by Valeant Pharmaceuticals in 2013. Prior to Bausch and Lomb, Barr was the CEO of AGA Medical, pioneer and leader in minimally invasive devices to repair structural heart defects and other vascular defects. Mr. Barr led a IPO for the Company in 2009 and the business was sold to St. Jude Medical in 2010.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master’s degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.
Andreas G. Frank was appointed senior vice president and president, Front Line Care, in December 2018. Mr. Frank joined Hill-Rom in 2011 as senior vice president, Corporate Development and Strategy, and most recently served in the additional role of chief transformation officer.
Prior to joining Hill-Rom, he served as director of Corporate Development and vice president, Business Development, at Danaher Corporation. He previously worked in the Corporate Finance and Strategy practice at McKinsey & Company. Mr. Frank earned master’s degrees in business administration and economics from the Otto Beisheim School of Management in Germany and The University of Texas at Austin, Red McCombs School of Business, respectively.
Dr. Adina Makover
Dr. Makover has managed venture capital investments in the biotech/ medical devices field for the past eight years, and joined ProSeed in 2006. Previously she held senior management positions in life sciences companies focusing on drugs, diagnostics and tissue engineering,Holding positions of CEO and Board Member, R&D, Process Development and Production Manager, Dr. Makover had responsibility for both technology and business aspects.
Dr. Makover holds a joint Ph.D degree in life sciences from Columbia University (USA) and Weizmann Institute of Science, (Israel) and did post- doctoral research at the Weizmann Institute in Israel. Dr. Makover also holds an MBA degree from Bar-Ilan University.
Mr. Nir earned his experience serving at several innovative and successful technology companies. He was most recently Senior Vice President, Corporate Marketing and General Manager of Consumer BU at SanDisk corporation (SNDK) until the acquisition by Western Digital Inc. (WDC) in 2016. Nir joined SanDisk in November 2006 through the acquisition of msystems Ltd (FLSH). Prior to that, he held sales and marketing positions at Destinator Ltd. and also co-founded and served as chief executive officer of MindEcho. Nir earned his bachelor’s degree in law and accounting and his master’s degree in business administration from Tel Aviv University.
Mr. Halperin is a veteran high tech executive. He has served in several senior management positions including CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and VP of Business Development at Lenslet.
He also led the R&D team at Eldat Communications (acquired by Pricer) and was the Department Head of an R&D Unit in the IDF Intelligence Corps where he won the Intelligence Innovation Award.
Mr. Halperin earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program.
Halperin was one of EarlySense’s founding team in 2004 and served as CEO of the company until 2019
David W. Bates, M.D.
Dr. Bates is an internationally acclaimed expert in patient safety. He is well known for using information technology to improve clinical decision-making, quality-of-care, cost-effectiveness, and outcomes assessment in medical practice.
Dr. Bates is Senior Vice President for Quality and Safety and Chief Quality Officer for Brigham and Women’s Hospital in Boston, MA. He maintains his positions as Chief of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, and Professor of Health Policy and Management at the Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. He also serves as Medical Director of Clinical and Quality Analysis, Information Systems for Partners Healthcare System.
Dr. Bates is a graduate of Stanford University and the Johns Hopkins School of Medicine. He began his fellowship in general internal medicine at Brigham and Women’s Hospital in 1988, and he received a M.Sc. in Health Policy and Management from the Harvard School of Public Health in 1990. He has been elected to the Institute of Medicine, the American Society for Clinical Investigation, the Association of American Physicians and the American College of Medical Informatics.
Robert M. Wachter, M.D.
Dr. Wachter is the Editor of the US Government’s two leading websites on safety, which receive about one million visits annually. He has also written two best-selling books on safety, including Understanding Patient Safety, the second edition of which was published in 2012.
In 2004, he received the John M. Eisenberg Award, the nation’s top honor in patient safety. For the past five years, Modern Healthcare magazine has named him one of the 50 most influential Physician Executives in the U.S. He was listed as number 14 in 2012.
Dr. Wachter has served on the Healthcare Advisory Boards of several companies, including Google. His blog, www.wachtersworld.org is one of the nation’s most popular healthcare blogs. In 2011, as a Fulbright Scholar, he studied patient safety and hospital medicine at Imperial College London.
Paul F. Levy
Mr. Levy is the former President and CEO of Beth Israel Deaconess Medical Center, a patient safety advocate and the author of the popular blog Not Running a Hospital.
He served from 2002 to 2011 as the President and Chief Executive Officer of the Beth Israel Deaconess Medical Center (BIDMC) in Boston, one of the world’s preeminent academic health centers.
Mr. Levy first received recognition at BIDMC in 2002 for organizing a turn-around that saved the hospital from financial disaster.
Mr. Levy is a strong advocate for quality and safety improvement and transparency of clinical outcomes. He is also the former Executive Dean for Administration at Harvard Medical School (HMS), where among other responsibilities he helped coordinate collaborative ventures between HMS and its affiliated hospitals.
Lynn M. Taussig, M.D.
Dr. Taussig was CEO of National Jewish Medical and Research Center for nearly 12 ½ years. Currently, he is a Special Advisor to the Provost (for the Life Sciences) at the University of Denver and a Consultant to National Jewish.
He serves as the Chair of the Steering Committee for the Childhood Asthma Research and Education (CARE) Network. Prior to assuming his position at National Jewish, he was Professor and Chair of the Department of Pediatrics and Director, Steele Children’s Research Center at the University of Arizona Health Sciences Center. He was on the faculty of the University of Arizona for 19 ½ years and began the Pediatric Pulmonary Section at that institution. In 1980, Dr. Taussig initiated the Tucson Children’s Respiratory Study, a major longitudinal study of the risk factors for asthma. The study continues today.
He is the author of more than 165 scientific publications and six books and monographs. He is a recipient of numerous honors and awards including the Alumni Achievement Award from Washington University School of Medicine, the Distinguished Achievement Award from the American Thoracic Society, and the Kendig Award from the American Academy of Pediatrics.
Dr. Taussig is a graduate of Harvard University and Washington University School of Medicine.
Andrew Collin, M.D.
Dr. Colin is a Professor of Pediatrics and the Director of the Division of Pediatric Pulmonology at Miller School of Medicine, University of Miami. He is certified by the American Board of Pediatrics in Pediatrics and Pediatric Pulmonology.
He received his MD at Technion, Israel Institute of Technology and completed his pediatric training in hospitals related to that medical school. He trained in Pediatric Pulmonology and Pediatric Intensive Care at Hadassah Hospital in Jerusalem and subsequently at Children`s Hospital Boston, Harvard Medical School. He served as Associate-Chief of a Technionaffiliated Department of Pediatrics in Haifa, Israel.
In 1990 he joined the Faculty of Children`s Hospital Boston, Harvard Medical School. He served as Clinical Director of the Division of Respiratory Diseases and was Associate Professor at Harvard Medical School. He actively participated in research and teaching and received the Klaus Peter International Teaching Award of Harvard Medical School, and was the first recipient of the Andrew A. Colin Teaching Award, named after him at Children`s Hospital, Boston.
Dr. Colin’s expertise includes: asthma, cystic fibrosis, structural and functional development of the respiratory system and related problems including lung diseases of prematurity, pediatric bronchoscopy and more.
Richard J. Martin, M.D.
Dr. Martin is the Chairman of the Department of Medicine at the National Jewish Medical and Research Center and Professor of Medicine at the National Jewish Medical and Research Center and the University of Colorado Health Sciences Center, Denver.
He holds the Edelstein Family Chair in Pulmonary Medicine. Dr. Martin is a member of the American College of Chest Physicians, American Thoracic Society, European Respiratory Society, American Federation for Clinical Research, American College of Physicians, American Association of Allergy Asthma and Immunology, and International Society for Chronobiology. His research interests are in the area of adult asthma, including airway inflammation, chronobiology and chronotherapy, nocturnal asthma, and the interaction of chronic infection and asthma.
In 2003, Dr. Martin was honored with the American College of Chest Physicians Distinguished Scholar Award in Respiratory Health. He has published more than 250 articles, books, and book chapters.
Dr. Martin received his medical degree from the University Of Michigan Medical School, Ann Arbor and completed residency training at Tulane University, New Orleans, Louisiana, and a Pulmonary Fellowship at the University of Oklahoma, Oklahoma City.
Mr. Lewis is Founder and President of the Disease Management Purchasing Consortium International, Inc. (DMPC–www.Dismgmt.com) which is the leading consultant/procurement broker in the field of Disease Management.
Mr. Lewis has published many articles on Disease Management. He is Founder and Past President of the Disease Management Association of America (www.DMAA.org), the official industry association. He is one of only two two-time winners (1999, 2004) of the DMAA’s Karen Coughlin Award for Outstanding Achievement in Disease Management. In 2002, The Disease Management Association of America created the Alfred B. Lewis Presidents Award.
Prior to founding the DMPC in 1996, Mr. Lewis had been Chairman and CEO (2003-2005) of CORE Inc., a Disability and Utilization Management Company. He holds an undergraduate and law degrees from Harvard University, Phi Beta Kappa and holds a Visiting Scholar Appointment at the Heller School for Social Policy, Brandeis University.